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consequence, clearly elevated levels in the circulation is seen only
in individuals with the most active disease. New assays that depict
cleavage neoepitopes of ECM-molecules, show a much more
clear distinction between healthy individuals from such affected by
osteoarthritis.
Territorial distribution: Collagen VI and biglycan are particularly
present in the territorial matrix close to the cells. At this time there
are no assays available for these proteins and they may show too
wide a tissue distribution for use as speciﬁc indicators of a process
in the cartilage. Temporal speciﬁcity is a result of the breakdown of
different proteins at different stages of the OA-process in the carti-
lage, e.g. demonstrated by stimulating cartilage breakdown using
cytokines relevant to the disease process. Available data show
that aggrecan is released in early phases, leaving the hyaluronan
binding part of the molecule in the tissue. COMP and ﬁbromodulin
are release at a later stage and the preferential cleavage of the
major collagen II and its release follows in a ﬁnal phase.
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Purpose: Multipotent mesenchymal stromal cells (MSC) are adult
stem cells characterized by their differentiation potential into mul-
tiple lineages and their immunosuppressive properties. This last
property is used here to evaluate the efﬁcacy of primary MSC
to inhibit inﬂammation-associated symptoms in the murine exper-
imental model of collagen-induced arthritis (CIA). Mesenchymal
stem cells (MSC) are considered suitable sources for cell-based
therapies in cartilage engineering. However, their potential to re-
generate a fully functional and mature tissue relies on the presence
of a differentiation factor. The identiﬁcation of such a factor spe-
ciﬁc for the chondrogenic lineage has still to be performed and
represents the major issue of this study.
Bone marrow-derived human MSC were induced to differenti-
ate towards chondrocytes using the micropellet culture technique
in presence of chondrogenic medium containing hBMP-2 for 21
days. Total RNA were hybridized on DNA microarrays (Affymetrix
U133A). Among the 1354 differentially regulated genes during
chondrogenesis, 705 genes were up-regulated in MSC-derived
chondrocytes. We ﬁrst focused our attention on transcription fac-
tors and in particular, on Foxo1A which was shown to be increased
by a 13-fold factor using real time PCR, as soon as day 2 of chon-
drogenesis. After the over-expression of the wtFoxo1A or mutated
Foxo1A genes in the C3H10T1/2 cells, we could show the up-
regulation of aggrecan, collagen IIB and the down-regulation of
collagen I, suggesting that Foxo1A is sufﬁcient to induce chondro-
genesis.
To demonstrate the immunosuppressive effect of MSC, we injected
the cells IV in arthritis. MSC were isolated from DBA1 mice and
wild type (wt), inducible nitric oxid synthase (iNOS)-/- or IL-6-/-
C57Bl6 mice. 106 MSC were intraveinously injected at various
times after collagen II immunization of DBA1 mice. Arthritis was
evaluated by the measure of paw swelling. In the CIA model, when
injected on day 18 and 24, syngeneic and allogeneic MSC were
able to signiﬁcantly decrease the incidence and clinical signs of
arthritis. Compared to wt MSC, iNOS-/- or IL-6-/- exhibited a highly
reduced immunosuppressive effect. When iNOS-/- or IL-6-/- MSC
were injected the clinical scores and incidence were signiﬁcantly
increased.
Conclusion. Foxo1A is one essential transcription factor involved
in the early steps of chondrogenesis. Moreover, allogeneic MSC
injection have anti-iﬂammatory effects through iNOS and that could
be relevant for osteoarthritis therapy.
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Purpose: There is growing recognition that the way that persons
cope with the pain of osteoarthritis not only inﬂuences their pain,
but also their psychological distress and physical disability. This
presentation provides an update on recent research in this area.
The presentation is divided into three sections. In the ﬁrst section,
a conceptual background for research on pain coping is presented.
The second section highlights recent research on key topics in the
arthritis pain coping literature include studies of active coping,
pain catastrophizing, biological mechanisms, and the effects of
pain coping skills training protocols. The ﬁnal section highlights
important new directions for research in this area including stud-
ies of partner-assisted coping interventions and the impact of
maladaptive pain coping behaviors (e.g. overeating, smoking).
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Purpose: Osteoarthritis (OA) is a common orthopaedic disease
seen in clinical canine patients and as such the dog is an often-
used model for study of OA. Histologic assessment of OA is
currently considered the “gold standard” for determining presence,
extent, and severity of disease. The vast majority of experimen-
tal and clinical canine OA studies have used the Mankin system
(Mankin et al. J Bone Joint Surg 1971;53A:523-37) or modiﬁ-
cations of this system to histologically evaluate OA. While this
methodology has produced useful data, limitations have been
suggested including: 1) lack of assessment of the joint as a whole,
2) inadequate representation of the relative importance of various
types of pathology, and 3) lack of a standardized methodology. The
purpose of our work was to ﬁrst develop and validate a histologic
assessment system to address these shortcomings, and then use
the novel system to examine stiﬂe joints in a prospective study
comparing three different canine models of OA.
Methods: The OARSI Histopathology Initiative Assessment Sys-
tem in the Dog was developed with a team of experts and analyzed
for reliability. For use of the system in the prospective study, sixteen
dogs received one of three different arthroscopic insults including
anterior cruciate ligament transection (n=5), full-thickness grooves
created on the medial femoral condyle (n=6), or release of the
caudal horn of the medial meniscus (n=5), to provoke OA in the
right stiﬂe (knee) joints. Dogs that received a sham surgery (n=5)
served as controls. Twelve weeks after surgery the dogs were
euthanatized and the operated stiﬂe joints and non-operated con-
tralateral stiﬂe joints were histologically evaluated using the OARSI
system and the Mankin system.
Results: The OARSI system was shown to be reliable for pro-
ducing consistent and repeatable scores and grades for cartilage,
osteochondral, and synovial tissue status. The data also suggest
that non-experienced observers using the system for the ﬁrst time
can effectively assess tissues to acceptable levels of agreement
with experts. In the prospective study, both the OARSI system and
Mankin system were judged acceptable for determining presence
and severity of OA. Statistically signiﬁcant differences among OA
severity categories were more often observed using the OARSI
system.
Conclusions: It is important to consider OA as a “whole organ
disease” and keep in mind that a tissue section does not always
